Shinya Suzu Selected Research

Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)

1/2018	Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphoma.
11/2013	M-CSF receptor mutations in hereditary diffuse leukoencephalopathy with spheroids impair not only kinase activity but also surface expression.
7/2011	Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinya Suzu Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 06/2002
8	Infections 10/2020 - 09/2009
5	Primary Effusion Lymphoma 01/2014 - 09/2009
5	Acquired Immunodeficiency Syndrome (AIDS) 03/2012 - 04/2005
3	Lymphoma (Lymphomas) 01/2019 - 09/2009
2	Virus Diseases (Viral Diseases) 11/2018 - 03/2010
2	Cholangiocarcinoma 07/2010 - 06/2010
2	Ascites 01/2010 - 09/2009
2	Leukemia 08/2007 - 08/2003
1	Splenomegaly 01/2019
1	Multiple Myeloma 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Hepatitis C 11/2018
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2018
1	HIV Infections (HIV Infection) 11/2015
1	Lung Neoplasms (Lung Cancer) 05/2014
1	Hereditary Diffuse Leukoencephalopathy with Spheroids 11/2013
1	Glioma (Gliomas) 12/2012
1	Chronic Hepatitis C 03/2010
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2010
1	Carcinogenesis 09/2009
1	Disease Progression 04/2005
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2005
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2003
1	Experimental Melanoma 06/2002
1	Neoplasm Metastasis (Metastasis) 06/2002

Drug/Important Bio-Agent (IBA)

7	Macrophage Colony-Stimulating FactorIBA 01/2019 - 06/2002
4	CytokinesIBA 01/2022 - 03/2010
4	src-Family KinasesIBA 03/2012 - 04/2005
3	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 01/2018 - 07/2011
3	Proteins (Proteins, Gene)FDA Link 04/2012 - 01/2008
3	Liposomes (Liposome)IBA 07/2010 - 03/2010
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 08/2003
2	LigandsIBA 01/2019 - 01/2018
2	Phosphotransferases (Kinase)IBA 11/2013 - 10/2010
2	NF-kappa B (NF-kB)IBA 07/2010 - 09/2009
2	cepharanthineIBA 07/2010 - 09/2009
2	Therapeutic UsesIBA 03/2010 - 01/2010
1	Trinitrotoluene (TNT)IBA 10/2020
1	ParaffinIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	romiplostim FDA Link 01/2019
1	elotuzumabIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 11/2018
1	Apolipoproteins E (ApoE)IBA 11/2018
1	InterleukinsIBA 01/2018
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2015
1	Adenosine Triphosphate (ATP)IBA 11/2015
1	Viral ProteinsIBA 11/2015
1	P2 peptideIBA 11/2015
1	MucinsIBA 09/2015
1	Immunoglobulins (Immunoglobulin)IBA 09/2015
1	HIV Protease InhibitorsIBA 01/2014
1	Lopinavir FDA Link 01/2014
1	Small Interfering RNA (siRNA)IBA 12/2012
1	Bromodeoxyuridine (BrdU)IBA 12/2012
1	5- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA 12/2012
1	Dimyristoylphosphatidylcholine (DMPC)IBA 06/2010
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2010
1	Ether (Diethyl Ether)IBA 06/2010
1	Ribavirin (Virazole)FDA LinkGeneric 03/2010
1	AlkaloidsIBA 09/2009
1	Reverse Transcriptase InhibitorsIBA 09/2009
1	Janus Kinase 3IBA 09/2009
1	islatravirIBA 09/2009
1	NucleosidesIBA 09/2009
1	fms-Like Tyrosine Kinase 3IBA 08/2003
1	GTP 14564IBA 08/2003
1	Tyrosine Kinase InhibitorsIBA 08/2003

Therapy/Procedure

2	Therapeutics 01/2018 - 05/2014
2	Drug Therapy (Chemotherapy) 03/2010 - 01/2010
1	Subcutaneous Injections 01/2010
1	Intraperitoneal Injections 09/2009